Successful treatment of hepatitis E virus-associated cryoglobulinemic membranoproliferative glomerulonephritis with ribavirin

Transplant Infectious Disease

Volumn 17, Issue 2, 2015, Pages 279-283

  Del Bello, A ^a,b   Guilbeau Frugier, C ^a,b   Josse, A G ^c   Rostaing, L ^a,b,d   Izopet, J ^b,c,d   Kamar, N ^a,b,d  

^a CHU RANGUEIL   (France)

^b UNIVERSITÉ PAUL SABATIER   (France)

^c Clinique du Pont de Chaume   (France)

^d CHU PURPAN   (France)

Author keywords

de novo glomerulopathy; Hepatitis E virus; Kidney transplantation; Membranoproliferative glomerulonephritis; Ribavirin

Indexed keywords

ALBUMIN; BASILIXIMAB; COMPLEMENT COMPONENT C3; CREATININE; HEPATITIS E ANTIBODY; HLA A ANTIGEN; HLA B ANTIGEN; HLA C ANTIGEN; HLA DP ANTIGEN; HLA DQ ANTIGEN; HLA DR ANTIGEN; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; IMMUNOGLOBULIN M ANTIBODY; IRBESARTAN; LIVER ENZYME; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; NOVEL ERYTHROPOIESIS STIMULATING PROTEIN; RECOMBINANT ERYTHROPOIETIN; RIBAVIRIN; STEROID; TACROLIMUS; VIRUS RNA; ANTIVIRUS AGENT; IMMUNOSUPPRESSIVE AGENT;

ADULT; ALPORT SYNDROME; ANAMNESIS; ANEMIA; ANTIVIRAL THERAPY; ARTICLE; BLOOD TRANSFUSION; CASE REPORT; CHRONIC HEPATITIS; CREATININE BLOOD LEVEL; CRYOGLOBULINEMIA; CRYOGLOBULINEMIC MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS; DISEASE ASSOCIATION; DRUG BLOOD LEVEL; DRUG DOSE REDUCTION; DRUG MEGADOSE; DRUG WITHDRAWAL; FATIGUE; GLOMERULUS BASEMENT MEMBRANE; GRAFT RECIPIENT; HEMATURIA; HEPATITIS E; HEPATITIS E VIRUS; HUMAN; HUMAN TISSUE; HYPERTENSION; IMMUNOFLUORESCENCE; IMMUNOGLOBULIN DEPOSITION; IMMUNOSUPPRESSIVE TREATMENT; JAUNDICE; KIDNEY ALLOGRAFT; KIDNEY BIOPSY; KIDNEY DYSFUNCTION; KIDNEY GRAFT; KIDNEY GRAFT REJECTION; LOW DRUG DOSE; MALE; MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS; MIDDLE AGED; ORGAN DONOR; PORK; PRIORITY JOURNAL; PROTEINURIA; RAW MEAT; REINFECTION; VIRAL CLEARANCE; GLOMERULONEPHRITIS, MEMBRANOPROLIFERATIVE; GRAFT REJECTION; IMMUNOCOMPROMIZED PATIENT; KIDNEY TRANSPLANTATION; NEPHRITIS, HEREDITARY; TREATMENT OUTCOME; VIROLOGY;

ANTIVIRAL AGENTS; CRYOGLOBULINEMIA; GLOMERULONEPHRITIS, MEMBRANOPROLIFERATIVE; GRAFT REJECTION; HEPATITIS E; HEPATITIS E VIRUS; HUMANS; IMMUNOCOMPROMISED HOST; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; NEPHRITIS, HEREDITARY; RIBAVIRIN; TRANSPLANT RECIPIENTS; TREATMENT OUTCOME;

EID: 84925359787     PISSN: 13982273     EISSN: 13993062     Source Type: Journal    
DOI: 10.1111/tid.12353     Document Type: Article

References (19)

1. Kamar N, Bendall R, Legrand-Abravanel F, et al. Hepatitis E. Lancet 2012; 379 (9835): 2477-2488.
2. Kamar N, Bendall R, Peron JM, et al. Hepatitis E virus and neurological disorders. Emerg Infect Dis 2011; 17 (2): 173-179.
3. Van den Berg B, Van der Eijk AA, Pas SD, et al. Guillain-Barré syndrome associated with preceding hepatitis E virus infection. Neurology 2014; 82 (6): 491-497.
4. Van Eijk JJ, Madden RG, Van der Eijk AA, et al. Neuralgic amyotrophy and hepatitis E virus infection. Neurology 2014; 82 (6): 498-503.
5. Kamar N, Weclawiak H, Guilbeau-Frugier C, et al. Hepatitis E virus and the kidney in solid organ transplant patients. Transplantation 2012; 93 (6): 617-623.
6. Taton B, Moreau K, Lepreux S, et al. Hepatitis E virus infection as a new probable cause of de novo membranous nephropathy after kidney transplantation. Transpl Infect Dis 2013; 15 (6): 211-215.
7. Fourquet E, Mansuy JM, Bureau C, et al. Severe thrombocytopenia associated with acute autochthonous hepatitis E. J Clin Virol 2010; 48 (1): 73-74.
8. Colson P, Payraudeau E, Leonnet C, et al. Severe thrombocytopenia associated with acute hepatitis E virus infection. J Clin Microbiol 2008; 46 (7): 2450-2452.
9. Kamar N, Izopet J, Tripon S, et al. Ribavirin for chronic hepatitis E virus infection in transplant recipients. N Engl J Med 2014; 370 (12): 1111-1120.
10. Abravanel F, Lhomme S, Chapuy-Regaud S, et al. Hepatitis E reinfections in solid organ-transplant recipients can evolve into chronic infections. J Infect Dis 2014; 209 (12): 1900-1906.
11. Kamar N, Dalton HR, Abravanel F, Izopet J. Hepatitis E virus infection. Clin Microbiol Rev 2014; 27 (1): 116-138.
12. Kamar N, Mansuy JM, Esposito L, et al. Acute hepatitis and renal function impairment related to infection by hepatitis E virus in a renal allograft recipient. Am J Kidney Dis 2005; 45 (1): 193-196.
13. Ali G, Kumar M, Bali SK, Wadhwa WB. Hepatitis E associated immune thrombocytopenia and membranous glomerulonephritis. Indian J Nephrol 2001; 11: 70-72.
14. Pischke S, Behrendt P, Manns MP, Wedemeyer H. HEV-associated cryoglobulinaemia and extra-hepatic manifestations of hepatitis E. Lancet Infect Dis 2014; 14 (8): 678-679.
15. Mallet V, Nicand E, Sultanik P, et al. Brief communication: case reports of ribavirin treatment for chronic hepatitis E. Ann Intern Med 2010; 153 (2): 85-89.
16. Kamar N, Rostaing L, Abravanel F, et al. Ribavirin therapy inhibits viral replication on patients with chronic hepatitis E virus infection. Gastroenterology 2010; 139 (5): 1612-1618.
17. Alric L, Plaisier E, Thebault S, et al. Influence of antiviral therapy in hepatitis C virus-associated cryoglobulinemic MPGN. Am J Kidney Dis 2004; 43 (4): 617-623.
18. Sabry AA, Sobh MA, Irving WL, et al. A comprehensive study of the association between hepatitis C virus and glomerulopathy. Nephrol Dial Transplant 2002; 17 (2): 239-245.
19. D'Amico G. Renal involvement in hepatitis C infection: cryoglobulinemic glomerulonephritis. Kidney Int 1998; 54 (2): 650-671.